Cucurbitacin B and SCH772984 exhibit synergistic anti-pancreatic cancer activities by suppressing EGFR, PI3K/Akt/mTOR, STAT3 and ERK signaling.

Zhou, Jingkai; Zhao, Tiangang; Ma, Linfeng; Liang, Min; Guo, Ying-Jie; Zhao, Li-Mei

Zhou, Jingkai; Zhao, Tiangang; Ma, Linfeng; Liang, Min; Guo, Ying-Jie; Zhao, Li-Mei.

Afiliación

Zhou J; Department of Pharmacy, Shengjing Hospital of China Medical University, Shenyang, China.
Zhao T; School of Life Sciences, Jilin University, Changchun, China.
Ma L; School of Life Sciences, Jilin University, Changchun, China.
Liang M; School of Life Sciences, Jilin University, Changchun, China.
Guo YJ; School of Life Sciences, Jilin University, Changchun, China.
Zhao LM; Department of Pharmacy, Shengjing Hospital of China Medical University, Shenyang, China.

Oncotarget ; 8(61): 103167-103181, 2017 Nov 28.

Article en En | MEDLINE | ID: mdl-29262554

Palabras clave

EGFR; ERK; SCH772984; cucurbitacin B; pancreatic cancer

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Oncotarget Año: 2017 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google